Type 2 diabetes heritability in the Tehran families: Tehran cardiometabolic genetic study

authors:

avatar Mahdi Akbarzadeh , avatar danial habibi , avatar Nadia Alipour , avatar Parisa Riahi , avatar Azra Ramezankhani , avatar Fereidoun Azizi ORCID , avatar Maryam S Daneshpour ORCID , *


how to cite: Akbarzadeh M, habibi D, Alipour N, Riahi P, Ramezankhani A, et al. Type 2 diabetes heritability in the Tehran families: Tehran cardiometabolic genetic study. koomesh. 2022;24(5):e152769. 

Abstract

Introduction: Type 2 diabetes, as a complex disorder, is one of the most prevalent endocrine disorders.  Importantly, the extent of familial aggregation and heritability in Iran is unknown. The aim of the present study was to determine type 2 diabetes heritability in the Tehran families. Materials and Methods: The current research comprises 1691 diabetic and 12050 non-diabetic individuals over 20 years who are participants in the Tehran Cardiometabolic Genetic Study (TCGS). In this research, the BGLR, gap, and S.A.G.E tools were used to conduct familial aggregation, family-based heritability, and segregation analysis. Results: Out of 13741 subjects, 45% were female, and 55% were male in 2594 constituent pedigrees. The results of intra-family correlation showed that there is a higher correlation among siblings (ICCbrother-sister = 0.26, ICCbrother-brother =0.16, ICCsister-sister =0.14) than mother-offspring (ICCmother-offsprings = 0.13) followed by father-son (ICCfather-son = 0.05). Besides, the results of logistic regression showed that the chances of developing diabetes are higher in people whose at least one parent had diabetes (OR=4.16). The heritability rate in this population was about 65% (SE=0.034). The segregation analysis showed that type 2 diabetes in this community follows a polygenic pattern. Conclusion: The heritability of type 2 diabetes with a polygenic pattern in Iran is higher than the global average. Type 2 diabetes is transmitted equally to siblings, and in terms of family history, parents are the most important risk factor for the disease. According to the findings of this research, it is recommended to shift the level of prevention from the individual to the family level in society when making health-system policy decisions.

References

  • 1.

    Karimi R, Nezhadali M, Hedayati M. Association of visfatin gene polymorphism rs4730153 with anthropometric characteristics, visfatin level, insulin resistance and lipid metabolism in Iranian diabetic/pre-diabetic population. Koomesh 2021; 23: 541-547. (Persian).##https://doi.org/10.52547/koomesh.23.5.541.

  • 2.

    Mtiraoui N, Turki A, Nemr R, Echtay A, Izzidi I, Al-Zaben GS, et al. Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPAR, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs. Diabetes Metab 2012; 38: 444-449.

  • 3.

    Hosseinpour-Niazi S, Bakhshi B, Zahedi AS, Akbarzadeh M, Daneshpour MS, Mirmiran P, et al. TCF7L2 polymorphisms, nut consumption, and the risk of metabolic syndrome: a prospective population based study. Nutr Metab (Lond) 2021; 18: 1-11.

  • 4.

    Khan IA, Poornima S, Jahan P, Rao P, Hasan Q. Type 2 diabetes mellitus and the association of candidate genes in Asian Indian population from Hyderabad, India. J Clin Diagnos Res 2015; 9: GC01.

  • 5.

    Zahedi AS, Akbarzadeh M, Sedaghati-Khayat B, Seyedhamzehzadeh A, Daneshpour MS. GCKR common functional polymorphisms are associated with metabolic syndrome and its components: a 10-year retrospective cohort study in Iranian adults. Diabetol Metab Syndr 2021; 13: 1-10.

  • 6.

    Alharbi KK, Abudawood M, Khan IA. Amino-acid amendment of Arginine-325-Tryptophan in rs13266634 genetic polymorphism studies of the SLC30A8 gene with type 2 diabetes-mellitus patients featuring a positive family history in the Saudi population. J King Saud Univ 2021; 33: 101258.##https://doi.org/10.1016/j.jksus.2020.101258.

  • 7.

    Daneshpour MS, Hedayati M, Sedaghati-Khayat B, Guity K, Zarkesh M, Akbarzadeh M, et al. Genetic identification for non-communicable disease: Findings from 20 years of the Tehran Lipid and Glucose Study. Int J Endocrinol Metab 2018; 16: e84744.

  • 8.

    Gopalakrishnan S, Geetha ARU. Study on the impact of family history of diabetes among type 2 diabetes mellitus patients in an urban area of Kancheepuram district, Tamil Nadu. Int J Commun Med Public Health 2017; 4.##https://doi.org/10.18203/2394-6040.ijcmph20174819.

  • 9.

    Guttmacher AE, Collins FS, Carmona RH. The family history-more important than ever. N Engl J Med 2004; 351: 2333-2336.

  • 10.

    Najafipour M, Zareizadeh M, Najafipour F. Epidemiologic study of familial type 2 diabetes in Tehran. J Adv Pharm Technol Res 2018; 9: 56.

  • 11.

    Whitford DL, McGee H, O'Sullivan B. Will people with type 2 diabetes speak to family members about health risk? Diabetes Care 2009; 32: 251-253.

  • 12.

    Balkau B, Roussel R, Wagner S, Tichet J, Froguel P, Fagherazzi G, et al. Transmission of Type 2 diabetes to sons and daughters: the DESIR cohort. Diabet Med 2017; 34: 1615-1622.

  • 13.

    Prasad RB, Groop L. Genetics of type 2 diabetes-pitfalls and possibilities. Genes (Basel) 2015; 6: 87-123.

  • 14.

    Doustmohamadian S, Kia NS, Fatahi S. Associated factors of poor glycemic control in Iranian diabetic patients TT, Koomesh 2021; 23: 372-378. (Persian).

  • 15.

    Alharbi KK, Al-Sulaiman AM, Bin Shedaid MK, Al-Shangiti AM, Marie M, Al-Sheikh YA, et al. MTNR1B genetic polymorphisms as risk factors for gestational diabetes mellitus: a case-control study in a single tertiary care center. Ann Saudi Med 2019; 39: 309-318.

  • 16.

    Yap CX, Sidorenko J, Wu Y, Kemper KE, Yang J, Wray NR, et al. Dissection of genetic variation and evidence for pleiotropy in male pattern baldness. Nat Commun 2018; 9: 1-12.

  • 17.

    Yang J, Zeng J, Goddard ME, Wray NR, Visscher PM. Concepts, estimation and interpretation of SNP-based heritability. Nat Genet 2017; 49: 1304-1310.

  • 18.

    Konigsberg LW. Quantitative variation and genetics. In: Human Biology: An Evolutionary and Biocultural Perspective: Second Edition. John Wiley Sons 2012; p. 143-73.##https://doi.org/10.1002/9781118108062.ch5.

  • 19.

    Daneshpour MS, Fallah MS, Sedaghati-Khayat B, Guity K, Khalili D, Hedayati M, et al. Rationale and design of a genetic study on cardiometabolic risk factors: protocol for the Tehran cardiometabolic genetic study (TCGS). JMIR Res Protoc 2017; 6: e28.

  • 20.

    Azizi F, Madjid M, Rahmani M, Emami H, Mirmiran P, Hadjipour R. Tehran Lipid and Glucose Study (TLGS): rationale and design. 2000. (Persian).

  • 21.

    Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C, et al. 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2020; 63: 221-228.

  • 22.

    Elston RC, Gray-McGuire C. A review of the'Statistical Analysis for Genetic Epidemiology'(SAGE) software package. Hum Genomics 2004; 1: 1-4.

  • 23.

    Rainer J, Taliun D, D'Elia Y, Pattaro C, Domingues FS, Weichenberger CX. FamAgg: an R package to evaluate familial aggregation of traits in large pedigrees. Bioinformatics 2016; 32: 1583-1585.

  • 24.

    Team RC. R: A language and environment for statistical computing. 2013.

  • 25.

    Ramezankhani A, Harati H, Bozorgmanesh M, Tohidi M, Khalili D, Azizi F, et al. Diabetes mellitus: findings from 20 years of the Tehran lipid and glucose study. Int J Endocrinol Metab 2018; 16.##https://doi.org/10.5812/ijem.84784.

  • 26.

    Zhao JH. gap: Genetic analysis package. J Stat Softw 2007; 23: 1-18.

  • 27.

    Akbarzadeh M, Dehkordi SR, Roudbar MA, Sargolzaei M, Guity K, Sedaghati-Khayat B, et al. GWAS findings improved genomic prediction accuracy of lipid profile traits: Tehran Cardiometabolic Genetic Study. Sci Rep 2021; 11: 1-9.

  • 28.

    de Los Campos G, Vazquez AI, Fernando R, Klimentidis YC, Sorensen D. Prediction of complex human traits using the genomic best linear unbiased predictor. PLoS Genet 2013; 9: e1003608.

  • 29.

    Gelman A, Rubin DB. Inference from iterative simulation using multiple sequences. Stat Sci 1992; 7: 457-472.##https://doi.org/10.1214/ss/1177011136.

  • 30.

    Ziegler A, Konig IR, Pahlke F. A Statistical Approach to Genetic Epidemiology: Concepts and Applications, with an E-learning platform. John Wiley & Sons; 2010.##https://doi.org/10.1002/9783527633654.

  • 31.

    Go RC, Elston RC, Kaplan EB. Efficiency and robustness of pedigree segregation analysis. Am J Hum Genet 1978; 30: 28.

  • 32.

    Zavala C, Morton NE, Rao DC, Lalouel JM, Gamboa IA, Tejeda A, et al. Complex segregation analysis of diabetes mellitus. Hum Hered 1979; 29: 325-333.

  • 33.

    Green A, Morton NE, Iselius L, Svejgaard A, Platz P, Ryder LP, et al. Genetic studies of insulindependent diabetes mellitus: segregation and linkage analyses. Tissue Antigens 1982; 19: 213-221.

  • 34.

    Turner RC, Hattersley AT, Shaw JT, Levy JC. Type II diabetes: clinical aspects of molecular biological studies. Diabetes 1995; 44: 1-10.

  • 35.

    Hanson RL, Elston RC, Pettitt DJ, Bennett PH, Knowler WC. Segregation analysis of non-insulin-dependent diabetes mellitus in Pima Indians: evidence for a major-gene effect. Am J Hum Genet 1995; 57: 160.

  • 36.

    Ramezankhani A, Guity K, Azizi F, Hadaegh F. Sex differences in the association between spousal metabolic risk factors with incidence of type 2 diabetes: a longitudinal study of the Iranian population. Biol Sex Differ 2019; 10: 1-8.

  • 37.

    Swan HJC. The framingham offspring study: A commentary. J Am Coll Cardiol 2000; 35: 13B-17B.##https://doi.org/10.1016/S0735-1097(00)80065-0.

  • 38.

    Lyssenko V, Groop L, Prasad RB. Genetics of type 2 diabetes: it matters from which parent we inherit the risk. Rev Diabet Stud RDS 2015; 12: 233.

  • 39.

    Uusitupa MI, Stankov A, Peltonen M, Eriksson JG, Lindstrm J, Aunola S, et al. Impact of positive family history and genetic risk variants on the incidence of diabetes: the Finnish Diabetes Prevention Study. Diabetes Care 2011; 34: 418-423.

  • 40.

    Li JK, Ng MC, So WY, Chiu CK, Ozaki R, Tong PC, et al. Phenotypic and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus. Diabetes Metab Res Rev 2006; 22: 46-52.

  • 41.

    De Silva SN, Weerasuriya N, De Alwis NM, De Silva MW, Fernando DJ. Excess maternal transmission and familial aggregation of Type 2 diabetes in Sri Lanka. Diabetes Res Clin Pract 2002; 58: 173-177.

  • 42.

    Rahim M, Rahim M, Rahim M, Sharafat S, Shaikh Z, Mamsa S, et al. Maternal and paternal transmission of diabetes: influence of nutritional factors. J Diabetes Metab 2015; 6.##https://doi.org/10.4172/2155-6156.1000504.

  • 43.

    Anokute CC. Suspected synergism between consanguinity and familial aggregation in type 2 diabetes mellitus in Saudi Arabia. J R Soc Health 1992; 112: 167-169.

  • 44.

    Al-Sinani S, Al-Shafaee M, Al-Mamari A, Woodhouse N, Al-Shafie O, Hassan M, et al. Familial clustering of type 2 diabetes among Omanis. Oman Med J 2014; 29: 51.

  • 45.

    Bener A, Yousafzai MT, Al-Hamaq AO. Familial aggregation of T2DM among Arab diabetic population. Int J Diabetes Dev Ctries 2012; 32: 90-92.##https://doi.org/10.1007/s13410-012-0071-5.

  • 46.

    Asamoah EA, Obirikorang C, Acheampong E, Annani-Akollor ME, Laing EF, Owiredu EW, et al. Heritability and genetics of type 2 diabetes mellitus in sub-saharan africa: a systematic review and meta-analysis. J Diabetes Res 2020; 2020.

  • 47.

    Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, Nyholt DR, et al. Common SNPs explain a large proportion of the heritability for human height. Nat Genet 2010; 42: 565-569.

  • 48.

    Akbarzadeh M, Moghimbeigi A, Morris N, Daneshpour MS, Mahjub H, Soltanian AR. A Bayesian structural equation model in general pedigree data analysis. Stat Anal Data Min ASA Data Sci J 2019; 12: 404-411.